nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PTGIR—Prostanoid ligand receptors—PTGER4—Crohn's disease	0.0391	0.0864	CbGpPWpGaD
Treprostinil—PTGIR—Eicosanoid ligand-binding receptors—PTGER4—Crohn's disease	0.026	0.0574	CbGpPWpGaD
Treprostinil—PTGIR—Small Ligand GPCRs—PTGER4—Crohn's disease	0.0215	0.0475	CbGpPWpGaD
Treprostinil—P2RY12—epithelium—Crohn's disease	0.0205	0.18	CbGeAlD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.0149	0.033	CbGpPWpGaD
Treprostinil—PPARD—mammalian vulva—Crohn's disease	0.0147	0.13	CbGeAlD
Treprostinil—PPARD—lymphoid tissue—Crohn's disease	0.0131	0.115	CbGeAlD
Treprostinil—PTGIR—epithelium—Crohn's disease	0.0131	0.115	CbGeAlD
Treprostinil—PPARD—digestive system—Crohn's disease	0.0129	0.114	CbGeAlD
Treprostinil—PTGIR—smooth muscle tissue—Crohn's disease	0.0126	0.111	CbGeAlD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—LRRK2—Crohn's disease	0.0115	0.0255	CbGpPWpGaD
Treprostinil—Sepsis—Mercaptopurine—Crohn's disease	0.0114	0.0262	CcSEcCtD
Treprostinil—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.0105	0.0243	CcSEcCtD
Treprostinil—Laryngeal pain—Mesalazine—Crohn's disease	0.0104	0.024	CcSEcCtD
Treprostinil—PTGIR—digestive system—Crohn's disease	0.00993	0.0876	CbGeAlD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—TAB1—Crohn's disease	0.00938	0.0207	CbGpPWpGaD
Treprostinil—Rectal haemorrhage—Mesalazine—Crohn's disease	0.00788	0.0181	CcSEcCtD
Treprostinil—Gout—Mesalazine—Crohn's disease	0.00762	0.0175	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00757	0.0167	CbGpPWpGaD
Treprostinil—PPARD—lymph node—Crohn's disease	0.00739	0.0651	CbGeAlD
Treprostinil—Neck pain—Mesalazine—Crohn's disease	0.0072	0.0166	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00696	0.0154	CbGpPWpGaD
Treprostinil—Melaena—Mesalazine—Crohn's disease	0.00695	0.016	CcSEcCtD
Treprostinil—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00654	0.0151	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00648	0.0143	CbGpPWpGaD
Treprostinil—Ecchymosis—Mesalazine—Crohn's disease	0.00643	0.0148	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00614	0.0136	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00596	0.0132	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.00586	0.0129	CbGpPWpGaD
Treprostinil—PTGIR—lymph node—Crohn's disease	0.00567	0.05	CbGeAlD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00565	0.0125	CbGpPWpGaD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.00563	0.0125	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCR9—Crohn's disease	0.00536	0.0118	CbGpPWpGaD
Treprostinil—Anaemia—Mercaptopurine—Crohn's disease	0.0053	0.0122	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00497	0.011	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—ACKR2—Crohn's disease	0.00494	0.0109	CbGpPWpGaD
Treprostinil—Arthralgia—Mercaptopurine—Crohn's disease	0.00488	0.0112	CcSEcCtD
Treprostinil—PTGIR—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00479	0.0106	CbGpPWpGaD
Treprostinil—Abdominal discomfort—Azathioprine—Crohn's disease	0.0047	0.0108	CcSEcCtD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—ICAM1—Crohn's disease	0.00469	0.0104	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00468	0.0103	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—MLN—Crohn's disease	0.00468	0.0103	CbGpPWpGaD
Treprostinil—Oedema—Mercaptopurine—Crohn's disease	0.00468	0.0108	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.00466	0.0103	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00462	0.0102	CbGpPWpGaD
Treprostinil—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00458	0.0105	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00457	0.0101	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—ACKR2—Crohn's disease	0.00454	0.01	CbGpPWpGaD
Treprostinil—Influenza—Mesalazine—Crohn's disease	0.00446	0.0103	CcSEcCtD
Treprostinil—Anorexia—Mercaptopurine—Crohn's disease	0.00446	0.0103	CcSEcCtD
Treprostinil—Pneumonia—Azathioprine—Crohn's disease	0.0044	0.0101	CcSEcCtD
Treprostinil—Contusion—Prednisone—Crohn's disease	0.00431	0.00993	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—MLN—Crohn's disease	0.00431	0.00952	CbGpPWpGaD
Treprostinil—Bronchitis—Mesalazine—Crohn's disease	0.00429	0.00988	CcSEcCtD
Treprostinil—Abdominal discomfort—Mesalazine—Crohn's disease	0.00428	0.00985	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00426	0.00981	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00426	0.00942	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00425	0.0094	CbGpPWpGaD
Treprostinil—Viral infection—Prednisone—Crohn's disease	0.00417	0.0096	CcSEcCtD
Treprostinil—Decreased appetite—Mercaptopurine—Crohn's disease	0.00407	0.00936	CcSEcCtD
Treprostinil—Pneumonia—Mesalazine—Crohn's disease	0.004	0.00922	CcSEcCtD
Treprostinil—Depression—Mesalazine—Crohn's disease	0.00397	0.00914	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00396	0.00876	CbGpPWpGaD
Treprostinil—Haemoglobin—Azathioprine—Crohn's disease	0.00394	0.00908	CcSEcCtD
Treprostinil—Haemorrhage—Azathioprine—Crohn's disease	0.00392	0.00903	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00392	0.00867	CbGpPWpGaD
Treprostinil—Urinary tract infection—Mesalazine—Crohn's disease	0.00387	0.00891	CcSEcCtD
Treprostinil—Haematuria—Mesalazine—Crohn's disease	0.0038	0.00874	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—SOCS1—Crohn's disease	0.00378	0.00837	CbGpPWpGaD
Treprostinil—Epistaxis—Mesalazine—Crohn's disease	0.00375	0.00864	CcSEcCtD
Treprostinil—Sinusitis—Mesalazine—Crohn's disease	0.00373	0.0086	CcSEcCtD
Treprostinil—Body temperature increased—Mercaptopurine—Crohn's disease	0.0037	0.00851	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00364	0.00806	CbGpPWpGaD
Treprostinil—Haemoglobin—Mesalazine—Crohn's disease	0.00359	0.00827	CcSEcCtD
Treprostinil—Rhinitis—Mesalazine—Crohn's disease	0.00358	0.00825	CcSEcCtD
Treprostinil—Haemorrhage—Mesalazine—Crohn's disease	0.00357	0.00823	CcSEcCtD
Treprostinil—CYP2C9—digestive system—Crohn's disease	0.00355	0.0313	CbGeAlD
Treprostinil—P2RY12—G alpha (i) signalling events—CCR6—Crohn's disease	0.00355	0.00785	CbGpPWpGaD
Treprostinil—Pharyngitis—Mesalazine—Crohn's disease	0.00355	0.00817	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00352	0.00778	CbGpPWpGaD
Treprostinil—Oedema peripheral—Mesalazine—Crohn's disease	0.00352	0.0081	CcSEcCtD
Treprostinil—Ecchymosis—Prednisone—Crohn's disease	0.0034	0.00784	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00329	0.00728	CbGpPWpGaD
Treprostinil—Sepsis—Prednisone—Crohn's disease	0.00327	0.00752	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—SMAD3—Crohn's disease	0.00327	0.00722	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCR9—Crohn's disease	0.00324	0.00717	CbGpPWpGaD
Treprostinil—Diarrhoea—Mercaptopurine—Crohn's disease	0.0032	0.00737	CcSEcCtD
Treprostinil—Ill-defined disorder—Azathioprine—Crohn's disease	0.00317	0.00729	CcSEcCtD
Treprostinil—Thrombophlebitis—Prednisone—Crohn's disease	0.00316	0.00727	CcSEcCtD
Treprostinil—Anaemia—Azathioprine—Crohn's disease	0.00316	0.00727	CcSEcCtD
Treprostinil—Erythema—Mesalazine—Crohn's disease	0.00311	0.00716	CcSEcCtD
Treprostinil—Malaise—Azathioprine—Crohn's disease	0.00308	0.00709	CcSEcCtD
Treprostinil—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00307	0.00679	CbGpPWpGaD
Treprostinil—Tension—Mesalazine—Crohn's disease	0.00305	0.00703	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00303	0.0067	CbGpPWpGaD
Treprostinil—Nervousness—Mesalazine—Crohn's disease	0.00302	0.00696	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—GPR65—Crohn's disease	0.00302	0.00667	CbGpPWpGaD
Treprostinil—Cardiac failure congestive—Prednisone—Crohn's disease	0.00301	0.00694	CcSEcCtD
Treprostinil—Back pain—Mesalazine—Crohn's disease	0.00301	0.00693	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00299	0.00662	CbGpPWpGaD
Treprostinil—Muscle spasms—Mesalazine—Crohn's disease	0.00299	0.00689	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCR9—Crohn's disease	0.00298	0.0066	CbGpPWpGaD
Treprostinil—Vomiting—Mercaptopurine—Crohn's disease	0.00297	0.00685	CcSEcCtD
Treprostinil—Rash—Mercaptopurine—Crohn's disease	0.00295	0.00679	CcSEcCtD
Treprostinil—Dermatitis—Mercaptopurine—Crohn's disease	0.00295	0.00678	CcSEcCtD
Treprostinil—Arthralgia—Azathioprine—Crohn's disease	0.00291	0.00669	CcSEcCtD
Treprostinil—Myalgia—Azathioprine—Crohn's disease	0.00291	0.00669	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.0029	0.00641	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Mesalazine—Crohn's disease	0.00289	0.00664	CcSEcCtD
Treprostinil—Anaemia—Mesalazine—Crohn's disease	0.00287	0.00662	CcSEcCtD
Treprostinil—Discomfort—Azathioprine—Crohn's disease	0.00287	0.00661	CcSEcCtD
Treprostinil—Angioedema—Mesalazine—Crohn's disease	0.00284	0.00654	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00282	0.00624	CbGpPWpGaD
Treprostinil—Malaise—Mesalazine—Crohn's disease	0.00281	0.00646	CcSEcCtD
Treprostinil—Cardiac failure—Prednisone—Crohn's disease	0.0028	0.00645	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL3—Crohn's disease	0.00279	0.00618	CbGpPWpGaD
Treprostinil—Syncope—Mesalazine—Crohn's disease	0.00279	0.00642	CcSEcCtD
Treprostinil—Nausea—Mercaptopurine—Crohn's disease	0.00278	0.0064	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—GPR65—Crohn's disease	0.00277	0.00614	CbGpPWpGaD
Treprostinil—Infection—Azathioprine—Crohn's disease	0.00277	0.00637	CcSEcCtD
Treprostinil—Palpitations—Mesalazine—Crohn's disease	0.00275	0.00633	CcSEcCtD
Treprostinil—Loss of consciousness—Mesalazine—Crohn's disease	0.00273	0.00629	CcSEcCtD
Treprostinil—Thrombocytopenia—Azathioprine—Crohn's disease	0.00273	0.00628	CcSEcCtD
Treprostinil—Cough—Mesalazine—Crohn's disease	0.00271	0.00625	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	0.0027	0.00598	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00267	0.0059	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PTRF—Crohn's disease	0.00266	0.00588	CbGpPWpGaD
Treprostinil—Arthralgia—Mesalazine—Crohn's disease	0.00265	0.0061	CcSEcCtD
Treprostinil—Chest pain—Mesalazine—Crohn's disease	0.00265	0.0061	CcSEcCtD
Treprostinil—Myalgia—Mesalazine—Crohn's disease	0.00265	0.0061	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—MLN—Crohn's disease	0.00264	0.00585	CbGpPWpGaD
Treprostinil—Anxiety—Mesalazine—Crohn's disease	0.00264	0.00608	CcSEcCtD
Treprostinil—Discomfort—Mesalazine—Crohn's disease	0.00262	0.00602	CcSEcCtD
Treprostinil—Hypotension—Azathioprine—Crohn's disease	0.0026	0.006	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.0026	0.00574	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00254	0.00585	CcSEcCtD
Treprostinil—Oedema—Mesalazine—Crohn's disease	0.00254	0.00584	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—ACKR2—Crohn's disease	0.00253	0.0056	CbGpPWpGaD
Treprostinil—Infection—Mesalazine—Crohn's disease	0.00252	0.00581	CcSEcCtD
Treprostinil—Shock—Mesalazine—Crohn's disease	0.0025	0.00575	CcSEcCtD
Treprostinil—Hypokalaemia—Prednisone—Crohn's disease	0.00249	0.00573	CcSEcCtD
Treprostinil—Thrombocytopenia—Mesalazine—Crohn's disease	0.00249	0.00572	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00248	0.00549	CbGpPWpGaD
Treprostinil—Tachycardia—Mesalazine—Crohn's disease	0.00248	0.0057	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—MLN—Crohn's disease	0.00243	0.00538	CbGpPWpGaD
Treprostinil—Anorexia—Mesalazine—Crohn's disease	0.00242	0.00557	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—F5—Crohn's disease	0.0024	0.00531	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MLN—Crohn's disease	0.0024	0.00531	CbGpPWpGaD
Treprostinil—Hypotension—Mesalazine—Crohn's disease	0.00237	0.00546	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00233	0.00516	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ACKR2—Crohn's disease	0.00233	0.00515	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00231	0.00533	CcSEcCtD
Treprostinil—Feeling abnormal—Azathioprine—Crohn's disease	0.0023	0.00529	CcSEcCtD
Treprostinil—Insomnia—Mesalazine—Crohn's disease	0.0023	0.00529	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00229	0.00505	CbGpPWpGaD
Treprostinil—Paraesthesia—Mesalazine—Crohn's disease	0.00228	0.00525	CcSEcCtD
Treprostinil—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00228	0.00525	CcSEcCtD
Treprostinil—Dyspnoea—Mesalazine—Crohn's disease	0.00226	0.00521	CcSEcCtD
Treprostinil—Dyspepsia—Mesalazine—Crohn's disease	0.00223	0.00515	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—F5—Crohn's disease	0.00221	0.00489	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MLN—Crohn's disease	0.00221	0.00489	CbGpPWpGaD
Treprostinil—Decreased appetite—Mesalazine—Crohn's disease	0.00221	0.00508	CcSEcCtD
Treprostinil—Abdominal pain—Azathioprine—Crohn's disease	0.0022	0.00507	CcSEcCtD
Treprostinil—Body temperature increased—Azathioprine—Crohn's disease	0.0022	0.00507	CcSEcCtD
Treprostinil—Fatigue—Mesalazine—Crohn's disease	0.00219	0.00504	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00218	0.00483	CbGpPWpGaD
Treprostinil—Pain—Mesalazine—Crohn's disease	0.00217	0.005	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CCR6—Crohn's disease	0.00215	0.00475	CbGpPWpGaD
Treprostinil—Depression—Prednisone—Crohn's disease	0.0021	0.00483	CcSEcCtD
Treprostinil—Feeling abnormal—Mesalazine—Crohn's disease	0.00209	0.00482	CcSEcCtD
Treprostinil—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00208	0.00478	CcSEcCtD
Treprostinil—Abdominal pain—Mesalazine—Crohn's disease	0.00201	0.00462	CcSEcCtD
Treprostinil—Body temperature increased—Mesalazine—Crohn's disease	0.00201	0.00462	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCR6—Crohn's disease	0.00198	0.00437	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	0.00196	0.00433	CbGpPWpGaD
Treprostinil—Bradycardia—Prednisone—Crohn's disease	0.00192	0.00443	CcSEcCtD
Treprostinil—Diarrhoea—Azathioprine—Crohn's disease	0.00191	0.00439	CcSEcCtD
Treprostinil—Haemoglobin—Prednisone—Crohn's disease	0.0019	0.00437	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—PTGER4—Crohn's disease	0.00189	0.00418	CbGpPWpGaD
Treprostinil—Haemorrhage—Prednisone—Crohn's disease	0.00189	0.00435	CcSEcCtD
Treprostinil—Dizziness—Azathioprine—Crohn's disease	0.00184	0.00424	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CCR9—Crohn's disease	0.00183	0.00405	CbGpPWpGaD
Treprostinil—Asthenia—Mesalazine—Crohn's disease	0.00182	0.00419	CcSEcCtD
Treprostinil—Pruritus—Mesalazine—Crohn's disease	0.0018	0.00414	CcSEcCtD
Treprostinil—Vomiting—Azathioprine—Crohn's disease	0.00177	0.00408	CcSEcCtD
Treprostinil—Rash—Azathioprine—Crohn's disease	0.00176	0.00405	CcSEcCtD
Treprostinil—Dermatitis—Azathioprine—Crohn's disease	0.00176	0.00404	CcSEcCtD
Treprostinil—Flushing—Prednisone—Crohn's disease	0.00175	0.00404	CcSEcCtD
Treprostinil—Headache—Azathioprine—Crohn's disease	0.00175	0.00402	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—PTGER4—Crohn's disease	0.00174	0.00385	CbGpPWpGaD
Treprostinil—Diarrhoea—Mesalazine—Crohn's disease	0.00174	0.004	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—GPR65—Crohn's disease	0.0017	0.00377	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR9—Crohn's disease	0.00169	0.00373	CbGpPWpGaD
Treprostinil—Dizziness—Mesalazine—Crohn's disease	0.00168	0.00387	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.00167	0.00369	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR9—Crohn's disease	0.00166	0.00368	CbGpPWpGaD
Treprostinil—Nausea—Azathioprine—Crohn's disease	0.00166	0.00381	CcSEcCtD
Treprostinil—Erythema—Prednisone—Crohn's disease	0.00165	0.00379	CcSEcCtD
Treprostinil—Vomiting—Mesalazine—Crohn's disease	0.00161	0.00372	CcSEcCtD
Treprostinil—Rash—Mesalazine—Crohn's disease	0.0016	0.00369	CcSEcCtD
Treprostinil—Dermatitis—Mesalazine—Crohn's disease	0.0016	0.00368	CcSEcCtD
Treprostinil—PPARD—Gene Expression—ZFP36L1—Crohn's disease	0.00159	0.00352	CbGpPWpGaD
Treprostinil—Headache—Mesalazine—Crohn's disease	0.00159	0.00366	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—GPR65—Crohn's disease	0.00157	0.00347	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PLA2G4F—Crohn's disease	0.00157	0.00347	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GPR65—Crohn's disease	0.00155	0.00342	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR9—Crohn's disease	0.00153	0.00339	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Prednisone—Crohn's disease	0.00153	0.00352	CcSEcCtD
Treprostinil—Anaemia—Prednisone—Crohn's disease	0.00152	0.0035	CcSEcCtD
Treprostinil—Nausea—Mesalazine—Crohn's disease	0.00151	0.00347	CcSEcCtD
Treprostinil—Angioedema—Prednisone—Crohn's disease	0.0015	0.00346	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—ACKR2—Crohn's disease	0.0015	0.00331	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—STAT3—Crohn's disease	0.00149	0.0033	CbGpPWpGaD
Treprostinil—Malaise—Prednisone—Crohn's disease	0.00148	0.00342	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—ITGA4—Crohn's disease	0.00148	0.00327	CbGpPWpGaD
Treprostinil—Syncope—Prednisone—Crohn's disease	0.00148	0.0034	CcSEcCtD
Treprostinil—Loss of consciousness—Prednisone—Crohn's disease	0.00145	0.00333	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—IL3—Crohn's disease	0.00144	0.00319	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GPR65—Crohn's disease	0.00142	0.00315	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MLN—Crohn's disease	0.00142	0.00314	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.00142	0.00313	CbGpPWpGaD
Treprostinil—Myalgia—Prednisone—Crohn's disease	0.0014	0.00323	CcSEcCtD
Treprostinil—Arthralgia—Prednisone—Crohn's disease	0.0014	0.00323	CcSEcCtD
Treprostinil—Anxiety—Prednisone—Crohn's disease	0.0014	0.00321	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—RASGRP1—Crohn's disease	0.00139	0.00308	CbGpPWpGaD
Treprostinil—Discomfort—Prednisone—Crohn's disease	0.00138	0.00319	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—ACKR2—Crohn's disease	0.00138	0.00304	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ITGA4—Crohn's disease	0.00136	0.00301	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—DNMT3A—Crohn's disease	0.00136	0.003	CbGpPWpGaD
Treprostinil—Oedema—Prednisone—Crohn's disease	0.00134	0.00309	CcSEcCtD
Treprostinil—Infection—Prednisone—Crohn's disease	0.00133	0.00307	CcSEcCtD
Treprostinil—PPARD—Metabolism—MTMR3—Crohn's disease	0.00133	0.00295	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL3—Crohn's disease	0.00133	0.00293	CbGpPWpGaD
Treprostinil—Shock—Prednisone—Crohn's disease	0.00132	0.00304	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.00132	0.00291	CbGpPWpGaD
Treprostinil—Tachycardia—Prednisone—Crohn's disease	0.00131	0.00302	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—MLN—Crohn's disease	0.00131	0.00289	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TAGAP—Crohn's disease	0.0013	0.00287	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—TNF—Crohn's disease	0.00129	0.00286	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—RASGRP1—Crohn's disease	0.00128	0.00284	CbGpPWpGaD
Treprostinil—Anorexia—Prednisone—Crohn's disease	0.00128	0.00295	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00122	0.00282	CcSEcCtD
Treprostinil—Insomnia—Prednisone—Crohn's disease	0.00121	0.0028	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CCR6—Crohn's disease	0.00121	0.00268	CbGpPWpGaD
Treprostinil—Paraesthesia—Prednisone—Crohn's disease	0.00121	0.00278	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—TAGAP—Crohn's disease	0.00119	0.00264	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—SMAD3—Crohn's disease	0.00119	0.00264	CbGpPWpGaD
Treprostinil—Dyspepsia—Prednisone—Crohn's disease	0.00118	0.00272	CcSEcCtD
Treprostinil—Decreased appetite—Prednisone—Crohn's disease	0.00117	0.00269	CcSEcCtD
Treprostinil—Fatigue—Prednisone—Crohn's disease	0.00116	0.00267	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00114	0.00253	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RSPO3—Crohn's disease	0.00113	0.00251	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.00113	0.00249	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR6—Crohn's disease	0.00112	0.00247	CbGpPWpGaD
Treprostinil—Feeling abnormal—Prednisone—Crohn's disease	0.00111	0.00255	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CCR6—Crohn's disease	0.0011	0.00244	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Prednisone—Crohn's disease	0.0011	0.00253	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—SEL1L—Crohn's disease	0.00108	0.00238	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PTGER4—Crohn's disease	0.00107	0.00236	CbGpPWpGaD
Treprostinil—Body temperature increased—Prednisone—Crohn's disease	0.00106	0.00244	CcSEcCtD
Treprostinil—Abdominal pain—Prednisone—Crohn's disease	0.00106	0.00244	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—RSPO3—Crohn's disease	0.00104	0.00231	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IL6—Crohn's disease	0.00104	0.0023	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—FADS1—Crohn's disease	0.00104	0.0023	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR6—Crohn's disease	0.00101	0.00224	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IL2RA—Crohn's disease	0.00101	0.00223	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SEL1L—Crohn's disease	0.000989	0.00219	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PTGER4—Crohn's disease	0.000984	0.00218	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR9—Crohn's disease	0.000983	0.00217	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GPX4—Crohn's disease	0.000972	0.00215	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PTGER4—Crohn's disease	0.000971	0.00215	CbGpPWpGaD
Treprostinil—Asthenia—Prednisone—Crohn's disease	0.000964	0.00222	CcSEcCtD
Treprostinil—Pruritus—Prednisone—Crohn's disease	0.00095	0.00219	CcSEcCtD
Treprostinil—PPARD—Metabolism—GCKR—Crohn's disease	0.000939	0.00208	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL2RA—Crohn's disease	0.000929	0.00205	CbGpPWpGaD
Treprostinil—Diarrhoea—Prednisone—Crohn's disease	0.000919	0.00212	CcSEcCtD
Treprostinil—PPARD—Gene Expression—HSPA1B—Crohn's disease	0.000915	0.00202	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GPR65—Crohn's disease	0.000914	0.00202	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL3—Crohn's disease	0.00091	0.00201	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000909	0.00201	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR9—Crohn's disease	0.000905	0.002	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PTGER4—Crohn's disease	0.000893	0.00198	CbGpPWpGaD
Treprostinil—Dizziness—Prednisone—Crohn's disease	0.000888	0.00204	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000881	0.00195	CbGpPWpGaD
Treprostinil—Vomiting—Prednisone—Crohn's disease	0.000854	0.00197	CcSEcCtD
Treprostinil—Rash—Prednisone—Crohn's disease	0.000847	0.00195	CcSEcCtD
Treprostinil—Dermatitis—Prednisone—Crohn's disease	0.000846	0.00195	CcSEcCtD
Treprostinil—Headache—Prednisone—Crohn's disease	0.000841	0.00194	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—GPR65—Crohn's disease	0.000841	0.00186	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL3—Crohn's disease	0.000838	0.00185	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000837	0.00185	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL3—Crohn's disease	0.000827	0.00183	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000826	0.00183	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00081	0.00179	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—UBE2D1—Crohn's disease	0.000803	0.00177	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RASGRP1—Crohn's disease	0.0008	0.00177	CbGpPWpGaD
Treprostinil—Nausea—Prednisone—Crohn's disease	0.000798	0.00184	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—IL3—Crohn's disease	0.000761	0.00168	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RASGRP1—Crohn's disease	0.000736	0.00163	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ALB—Crohn's disease	0.00073	0.00161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000708	0.00157	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCL8—Crohn's disease	0.000692	0.00153	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—JAK2—Crohn's disease	0.000678	0.0015	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ALB—Crohn's disease	0.000671	0.00148	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000671	0.00148	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR6—Crohn's disease	0.000651	0.00144	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2RA—Crohn's disease	0.000638	0.00141	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCL8—Crohn's disease	0.000637	0.00141	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—JAK2—Crohn's disease	0.000624	0.00138	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000602	0.00133	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR6—Crohn's disease	0.000599	0.00133	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RBX1—Crohn's disease	0.000589	0.0013	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000587	0.0013	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2RA—Crohn's disease	0.000587	0.0013	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2RA—Crohn's disease	0.000579	0.00128	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SMAD3—Crohn's disease	0.000574	0.00127	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTGER4—Crohn's disease	0.000573	0.00127	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RBX1—Crohn's disease	0.000542	0.0012	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2RA—Crohn's disease	0.000533	0.00118	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTGER4—Crohn's disease	0.000528	0.00117	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—UBE2D1—Crohn's disease	0.000516	0.00114	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RIPK2—Crohn's disease	0.000501	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL3—Crohn's disease	0.000488	0.00108	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—UBE2D1—Crohn's disease	0.000475	0.00105	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RASGRP1—Crohn's disease	0.000472	0.00104	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000469	0.00104	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RIPK2—Crohn's disease	0.000461	0.00102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL3—Crohn's disease	0.000449	0.000994	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000439	0.000971	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RASGRP1—Crohn's disease	0.000435	0.000961	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—JAK2—Crohn's disease	0.000429	0.000948	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SOCS1—Crohn's disease	0.000428	0.000946	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—TYK2—Crohn's disease	0.000408	0.000902	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—JAK2—Crohn's disease	0.000395	0.000872	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SOCS1—Crohn's disease	0.000394	0.000871	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—Crohn's disease	0.000391	0.000865	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—JAK2—Crohn's disease	0.000389	0.000861	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—TYK2—Crohn's disease	0.000376	0.00083	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SMAD3—Crohn's disease	0.00037	0.000817	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—Crohn's disease	0.00036	0.000796	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—JAK2—Crohn's disease	0.000358	0.000792	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—Crohn's disease	0.000355	0.000786	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2RA—Crohn's disease	0.000342	0.000757	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SMAD3—Crohn's disease	0.00034	0.000752	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—Crohn's disease	0.000327	0.000723	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	0.000315	0.000697	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2RA—Crohn's disease	0.000315	0.000696	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—Crohn's disease	0.000299	0.000661	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTMR3—Crohn's disease	0.000268	0.000593	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—Crohn's disease	0.000262	0.000578	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TYK2—Crohn's disease	0.000241	0.000533	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JAK2—Crohn's disease	0.00023	0.000508	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TYK2—Crohn's disease	0.000222	0.000491	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JAK2—Crohn's disease	0.000212	0.000468	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—Crohn's disease	0.00021	0.000464	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FADS1—Crohn's disease	0.000209	0.000462	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—Crohn's disease	0.0002	0.000441	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX4—Crohn's disease	0.000196	0.000432	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—Crohn's disease	0.000193	0.000427	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCKR—Crohn's disease	0.000189	0.000418	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—Crohn's disease	0.000184	0.000406	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—Crohn's disease	0.000169	0.000373	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—Crohn's disease	0.000155	0.000343	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000135	0.000298	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000118	0.000261	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—Crohn's disease	0.000118	0.000261	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—Crohn's disease	0.000108	0.00024	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—Crohn's disease	6.01e-05	0.000133	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—Crohn's disease	5.26e-05	0.000116	CbGpPWpGaD
